Govt raises ceiling prices of BCG, Measles vaccines by 21%
AI Summary
The government's decision to raise the ceiling prices for BCG, Measles, and Measles-Rubella vaccines by 21% comes after the Serum Institute of India contested an earlier pricing order. This move is intended to alleviate the manufacturer's financial concerns while ensuring that these essential vaccines remain accessible and affordable for the public. This adjustment underscores the government's commitment to maintaining robust public health infrastructure by securing a steady supply of crucial immunizations.
Original Source
Read the full article at Timesofindia →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.